What Researchers Did
This review article summarized the current understanding of hyperbaric oxygen therapy (HBOT) for veterans with post-traumatic stress disorder (PTSD), including its physiological basis and available clinical evidence.
What They Found
Post-traumatic stress disorder (PTSD) affects up to 30% of veterans, with a substantial proportion not responding to current treatments. This review found that HBOT has shown beneficial effects in veterans with treatment-resistant PTSD, moderating symptoms like intrusive thoughts and hyperarousal, and correlating with improved brain function and structural changes.
What This Means for Canadian Patients
For Canadian veterans experiencing treatment-resistant PTSD, hyperbaric oxygen therapy (HBOT) could potentially offer a new therapeutic option to alleviate symptoms. Patients should discuss this emerging treatment with their healthcare providers to understand its potential benefits and risks in their specific situation.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review, this article synthesizes existing data, and its findings are dependent on the quality and scope of the studies included.